Models of metastatic prostate cancer: a transgenic perspective (Q35217386)

7 August 2017

1 reference

title

Models of metastatic prostate cancer: a transgenic perspective (English)

1 reference

7 August 2017

1 reference

Winter SF

1

1 reference

PubMed ID

12970722

7 August 2017

Cooper AB

series ordinal

2

1 reference

PubMed ID

12970722

7 August 2017

Greenberg NM

series ordinal

3

1 reference

7 August 2017

1 January 2003

1 reference

Prostate Cancer and Prostatic Diseases

7 August 2017

1 reference

7 August 2017

6

1 reference

7 August 2017

3

1 reference

7 August 2017

204-211

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.pcan.4500655

7 August 2017

0 references

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

The pathogenesis of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

The role of cell adhesion molecules and proteases in tumor invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

The distribution of secondary growths in cancer of the breast. 1889

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Factors regulating the growth of metastatic cancer in bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Defining the biologic role of genes that regulate prostate cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Lobund-Wistar rat model of prostate cancer in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Sequential observation of rat prostate lesion development induced by 3,2'-dimethyl-4-aminobiphenyl and testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Neuroendocrine differentiation in human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Molecular characterization of a metastatic neuroendocrine cell cancer arising in the prostates of transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

MMP inhibition in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

E-cadherin mediated adhesion system in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Internal ribosomal entry site-containing retroviral vectors with green fluorescent protein and drug resistance markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Visualizing the kinetics of tumor-cell clearance in living animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

PET imaging of transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

The R-3327 system of rat prostatic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Prostatic tumor (R3327) skeletal metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Workgroup 4: spontaneous prostate carcinoma in dogs and nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Pathologic progression of autochthonous prostate cancer in the TRAMP model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Pathobiology of autochthonous prostate cancer in a pre‐clinical transgenic mouse model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Examining the role of Paneth cells in the small intestine by lineage ablation in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Do neuroendocrine cells in human prostate cancer express androgen receptor?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Circulating neuroendocrine markers in patients with prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.PCAN.4500655

7 January 2021

Identifiers

DOI

10.1038/SJ.PCAN.4500655

1 reference

7 August 2017

1 reference

PubMed ID

12970722